Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
IMUC

ImmunoCellular

$0.22

-0.0066 (-2.90%)

16:07
12/13/17
12/13
16:07
12/13/17
16:07
Hot Stocks
ImmunoCellular achieves key milestone in Stem-to-T-Cell immuno-oncology program »

ImmunoCellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
IMUC

ImmunoCellular

$0.30

0.0207 (7.33%)

16:13
09/13/17
09/13
16:13
09/13/17
16:13
Hot Stocks
ImmunoCellular's plan of compliance accepted by NYSE »

ImmunoCellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUC

ImmunoCellular

$0.36

-0.0122 (-3.30%)

16:08
08/23/17
08/23
16:08
08/23/17
16:08
Hot Stocks
ImmunoCellular to refocus resources on Stem-to-T-Cell research program »

ImmunoCellular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

IMUC

ImmunoCellular

$0.37

0.036 (10.78%)

07:25
08/23/17
08/23
07:25
08/23/17
07:25
Conference/Events
ImmunoCellular to host conference call »

Business News Update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

IMUC

ImmunoCellular

$0.32

-0.0191 (-5.65%)

09:56
08/18/17
08/18
09:56
08/18/17
09:56
Conference/Events
ImmunoCellular to host conference call »

Business News Update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

IMUC

ImmunoCellular

$0.38

-0.0999 (-20.81%)

12:11
07/19/17
07/19
12:11
07/19/17
12:11
Hot Stocks
Breaking Hot Stocks news story on ImmunoCellular »

Empery Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUC

ImmunoCellular

$1.22

0.19 (18.45%)

06:35
07/18/17
07/18
06:35
07/18/17
06:35
Syndicate
ImmunoCellular raises $5M in a convertible preferred stock and warrant offering »

ImmunoCellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUC

ImmunoCellular

$1.08

0.1829 (20.32%)

10:28
07/05/17
07/05
10:28
07/05/17
10:28
Hot Stocks
Breaking Hot Stocks news story on ImmunoCellular »

ImmunoCellular halted for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUC

ImmunoCellular

$0.87

-0.02 (-2.25%)

16:15
06/29/17
06/29
16:15
06/29/17
16:15
Earnings
ImmunoCellular receives NYSE non-compliance letter »

ImmunoCellular has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUC

ImmunoCellular

$0.87

-0.0312 (-3.47%)

06:03
06/21/17
06/21
06:03
06/21/17
06:03
Hot Stocks
ImmunoCellular to suspend further patient randomization for ICT-107 trial »

ImmunoCellular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.